άÐÞÖ÷¹Ü н×ÊÃæÒé ÊÕ²Ø ÉêÇëְλ
Ê×Ò³ > Ì©ÖÝÕÐÆ¸ > άÐÞÖ÷¹Ü

άÐÞÖ÷¹Ü

Ì©ÖÝÂõ²©Ì«¿ÆÒ©ÒµÓÐÏÞ¹«Ë¾

Ë¢ÐÂÓÚ£º2021-02-18±»ä¯ÀÀ£º2433´Î

н×ÊÃæÒé

²»ÏÞ / ѧÀú²»ÏÞ / ÐÔ±ð²»ÏÞ / 1 / ²»ÏÞµ½¸Ú

½­ËÕ-Ì©ÖÝ £¨Ì©ÖÝÒ½Ò©¸ßм¼Êõ²úÒµÔ°¿Ú̩·Î÷²à½¼Ò·¶«²àG79´± £© Éϰà·Ïß²éѯ

ÕÐÆ¸1

³Â
ְλ·¢²¼ÈË£º³ÂÏÈÉú

139****6549,052****713092 ÏÔʾºÅÂë

(ÁªÏµÊ±Çë˵Ã÷ÊÇÔÚÐÂÌ©ÖÝÈ˲ÅÍøÉÏ¿´µ½µÄ)

´òµç»°Ç°ÏÈͶ¸ö¼òÀú£¬»ñµÃÃæÊԵijɹ¦ÂÊÔö¼Ó30%

Ì©ÖÝÈ˲ÅÍøÌáʾ£ºÌ©ÖÝÂõ²©Ì«¿ÆÒ©ÒµÓÐÏÞ¹«Ë¾ÎÞȨÊÕÈ¡ÈκηÑÓã¬Çë¹ã´óÇóÖ°Õß¼ÓÇ¿×ÔÎÒ±£»¤Òâʶ£¬°´ÀͶ¯·¨¹æ±£»¤×ÔÉíÈ¨Òæ£¬¾¯ÌèÐé¼ÙÕÐÆ¸,±ÜÃâÉϵ±ÊÜÆ­£¡ ¾Ù±¨´Ëְλ
ְλÃèÊö

¸ÚλְÔð£º1¸ºÔð¹«Ë¾ÄÚÉ豸ÉèÊ©µÄά»¤Î¬ÐÞ¹¤×÷£¬È·±£É豸Õý³£ÔËÐУ»

2±àдËù¸ºÔðÉ豸µÄά»¤Î¬ÐÞSOP£¬²¢¶½´ÙÖ´ÐУ¬È·±£Æä·ûºÏGMPÒªÇó£»

3ÖÆ¶©É豸ÉèÊ©µÄÄê¶Èά»¤±£Ñø¼Æ»®£¬²¢Íƶ¯ÊµÊ©£»

4¶ÔÉ豸ά»¤±£Ñø¼Ç¼½øÐÐÉóºËͳ¼ÆºÍ·ÖÎö£¬Ìá¸ßÉ豸µÄά»¤Ð§ÂʺÍÉ豸µÄÔËÐпɿ¿ÐÔ£¬½µµÍÉ豸µÄÍ£»

úÂÊ£»

5×é֯ά»¤ÈËÔ±°´Õչ淶ºÍSOP¶Ô¸÷ϵͳ½øÐж¨ÆÚµã¼ìºÍά»¤£»

6¼°Ê±´¦ÀíÏÖ³¡½ô¼±×´¿öºÍÍ»·¢Ê¼þ£¬È·±£²»Ó°ÏìÕý³£µÄÉú²ú£»

7²ÎÓ빤³ÌÏîÄ¿µÄ½¨É裬ΪËù¸ºÔðרҵÌṩ¼¼ÊõÖ§³Ö£»

8¼Æ»®Ð­µ÷Åàѵ£¬²»¶ÏÌá¸ßÏÂÊôÔ±¹¤¹¤×÷¼¼ÄÜ£¬¹Ø×¢Ô±¹¤¸öÈË·¢Õ¹£»

9Íê³ÉÁìµ¼½»°ìµÄÆäËû¹¤×÷ÈÎÎñ¡£
ÈÎÖ°ÒªÇó£º1×Ô¶¯»¯µÈ¹¤³ÌÏà¹ØÁìÓòרҵ±ÏÒµ£¬±¾¿Æ¼°ÒÔÉÏѧÀú£»

28ÄêÒÔÉÏÖÆÒ©É豸ά»¤¹¤×÷¾­Ñ飬1ÄêÒÔÉϹÜÀí¹¤×÷¾­Ñ飬կÎÕÎÞ¾úÖÆ¼ÁÁª¶¯ÏßÉ豸άÐÞ¼¼ÄÜ£»

3ÓÐÁ¼ºÃµÄÎļþ±àдÄÜÁ¦£¬Äܹ»°´ÕÕGMPµÈ·¨¹æµÄÒªÇó±àдËù¸ºÔðϵͳµÄSOP¼°È·ÈÏÎļþ£»

4ÊìϤÖйúGMPµÈÖÆÒ©ÁìÓò·¨¹æÒªÇó£¬ÓÐGMPÈÏÖ¤¾­ÑéÓÅÏÈ£»

5ÊìÁ·²Ù×÷CAD»æÍ¼¼°°ì¹«Èí¼þ£»

6¹¤×÷ÔðÈÎÐÄÇ¿£¬ÄܳÐÊܽϴó¹¤×÷ѹÁ¦£¬ÓнÏÇ¿µÄ¹µÍ¨Ð­µ÷ÄÜÁ¦£¬¼Æ»®ÓëÖ´ÐÐÄÜÁ¦Ç¿¡£

¹«Ë¾¼ò½é
Ì©ÖÝÂõ²©Ì«¿ÆÒ©ÒµÓÐÏÞ¹«Ë¾ÓÚ2015ÄêÈëפ̩ÖÝÊÐÖйúÒ½Ò©³Ç£¬×¢²á×ʱ¾2000ÍòÃÀÔª¡£¹«Ë¾Ö÷Òª´Óʵ¥¿¹Ò©ÎïÉú²ú£¬Í¶×Ê×ܶî2ÒÚÃÀÔª£¬Ä⽨³§·¿Ãæ»ý3ÍòÓàÆ½·½£¬½¨Éè·ûºÏGMP±ê×¼µÄ¹ú¼ÊÏȽøµÄ¿¹ÌåÒ©ÎïÖÆ±¸Ìåϵ£¬ÒÔÆÚ´òÔì¹úÄÚ¿¹ÌåÒ©ÎïÉú²ú¸ßµØ¡£Âõ²©Ì«¿ÆÒ©ÒµÓÉÉϺ£ÕŽ­ÉúÎï¼¼ÊõÓÐÏÞ¹«Ë¾£¨¿¹ÌåÒ©ÎïÓë°ÐÏòÖÎÁƹú¼ÒÖØµãʵÑéÊÒ£©¿¹ÌåÑз¢ÍŶÓÌṩһվʽƽ̨·þÎñ£¬ÖÂÁ¦ÓÚʵÏÖһϵÁÐÖØÁ¿¼¶¹ú¼Ò´´Ð¿¹ÌåÒ©ÎïµÄ²úÒµ»¯¡£ÏÖÓÐÆ·ÖÖ£ºÖÎÁƽáÖ±³¦°©µÄÖØ×鿹EGFRÈËÊóǶºÏµ¥¿Ë¡¿¹Ì壬ÖÎÁÆÒøÐ¼²¡µÄÖØ×éÈËLFA3-¿¹ÌåÈںϵ°°×µÈ¡£TaizhouMabtechPharmaceuticalCo.,Ltd.joinedtheChinaMedicalCity(CMC)in2015withregisteredcapitalofUSD20million,expandinganationalhighlandformonoclonalantibodymedicinemanufacturingbyestablishinginternationallyadvancedantibodymedicinemanufacturesystemwithadoptedcGMPstandards,withatotalinvestmentofUSD200million.Supportedbytheone-stopplatformfortherapeuticmAbmedicinedevelopmentprovidedbyZJ-BioR&DTeam(StateKeyLaboratoryofAntibodyMedicineandTargetedTherapy),TaizhouMabtechPharmaceuticsCo.,Ltdisdedicatedtoindustrializationofaseriesof¡°blockbuster¡±innovativeantibodydrugs.Existingvarieties:recombinantanti-EGFRhuman/mouse-chimericmonoclonalantibodyforthetreatmentofcolorectalcancer,recombinanthumanLFA3-antibodyfusionproteinforthetreatmentofpsoriasis,etal.
¸Ã¹«Ë¾µÄÆäTAְλ
Ì©ÖÝÂõ²©Ì«¿ÆÒ©ÒµÓÐÏÞ¹«Ë¾
  • ÖÆÔìÒµ
  • ÍâÉÌͶ×ÊÆóÒµ
  • ½­ËÕ-Ì©ÖÝ
  • 100-1000ÈË
0%¼òÀú·´À¡ÂÊ
0ƽ¾ù»Ø¸´Ê±³¤
0¸öÕÐÆ¸Ö°Î»
ְλÃû³Æ£ºÎ¬ÐÞÖ÷¹Ü
¹«Ë¾Ãû³Æ£º Ì©ÖÝÂõ²©Ì«¿ÆÒ©ÒµÓÐÏÞ¹«Ë¾
 
ÏàËÆÖ°Î»
  • µçº¸¹¤
    ÃæÒé Ì©ÖÝ-Ì©ÐË
    ½­ËÕ¶¦ÍúÒ±½ð²ÄÁÏÓÐÏÞ¹«Ë¾
  • ÒÇ±í¹¤
    7ǧ-8ǧ5/Ô ̩ÖÝ-Ì©ÐË
    ½­ËÕÌ©ÌØ¶ûвÄÁϿƼ¼¹É·ÝÓÐÏÞ¹«Ë¾
  • ÉÌÎñ˾»ú
    ÃæÒé Ì©ÖÝ-Ì©ÐË
    Ì©ÐËÊи£Àû½¨Öþ°²×°¹¤³ÌÓÐÏÞ¹«Ë¾
  • µçÒǹ¤³Ìʦ
    6ǧ-1Íò2/Ô ̩ÖÝ-Ì©ÐË
    ½­ËÕÌ©ÌØ¶ûвÄÁϿƼ¼¹É·ÝÓÐÏÞ¹«Ë¾
  • µçÒǹ¤
    ÃæÒé Ì©ÖÝ-Ì©ÐË
    Ì©ÐËÊЕN¿Æ»¯¹¤ÓÐÏÞ¹«Ë¾